Compare, Analyse Panacea Biotech with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs MYLAN (US) - Comparison Results

PANACEA BIOTECH     Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PANACEA BIOTECH   MYLAN
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-18
MYLAN
Dec-18
PANACEA BIOTECH/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3643,390-   
Low Rs1291,866-   
Sales per share (Unadj.) Rs96.81,559.9-  
Earnings per share (Unadj.) Rs-12.442.4-  
Cash flow per share (Unadj.) Rs-2.9334.4-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs50.41,687.5-  
Shares outstanding (eoy) m61.25514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.51.7 151.2%   
Avg P/E ratio x-19.962.0 -32.0%  
P/CF ratio (eoy) x-86.47.9 -1,100.0%  
Price / Book Value ratio x4.91.6 314.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m15,1011,352,115 1.1%   
No. of employees `0002.535.0 7.1%   
Total wages/salary Rs m1,5160-   
Avg. sales/employee Rs Th2,401.922,930.8 10.5%   
Avg. wages/employee Rs Th614.20-   
Avg. net profit/employee Rs Th-307.9622.7 -49.5%   
INCOME DATA
Net Sales Rs m5,928802,578 0.7%  
Other income Rs m820-   
Total revenues Rs m6,010802,578 0.7%   
Gross profit Rs m845207,678 0.4%  
Depreciation Rs m585150,274 0.4%   
Interest Rs m1,00638,601 2.6%   
Profit before tax Rs m-66418,802 -3.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m99-2,991 -3.3%   
Profit after tax Rs m-76021,793 -3.5%  
Gross profit margin %14.325.9 55.1%  
Effective tax rate %-14.9-15.9 93.4%   
Net profit margin %-12.82.7 -472.1%  
BALANCE SHEET DATA
Current assets Rs m5,603448,159 1.3%   
Current liabilities Rs m6,910326,757 2.1%   
Net working cap to sales %-22.015.1 -145.7%  
Current ratio x0.81.4 59.1%  
Inventory Days Days20684 246.3%  
Debtors Days Days8493 89.7%  
Net fixed assets Rs m9,941155,687 6.4%   
Share capital Rs m61427 14.3%   
"Free" reserves Rs m3,0260-   
Net worth Rs m3,087868,243 0.4%   
Long term debt Rs m5,707937,113 0.6%   
Total assets Rs m16,0762,328,965 0.7%  
Interest coverage x0.31.5 22.9%   
Debt to equity ratio x1.81.1 171.3%  
Sales to assets ratio x0.40.3 107.0%   
Return on assets %1.52.6 59.0%  
Return on equity %-24.62.5 -980.9%  
Return on capital %3.93.2 123.2%  
Exports to sales %24.00-   
Imports to sales %17.50-   
Net fx Rs m4690-   
CASH FLOW
From Operations Rs m1,180166,776 0.7%  
From Investments Rs m553-86,205 -0.6%  
From Financial Activity Rs m-1,644-77,694 2.1%  
Net Cashflow Rs m901,382 6.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.22 Rs / USD

Compare PANACEA BIOTECH With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare PANACEA BIOTECH With: PIRAMAL ENTERPRISES  GLENMARK PHARMA  FRESENIUS KABI ONCO.  JUBILANT LIFE SCIENCES  PLETHICO PHARMA  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views On News

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Oct 18, 2019 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 8-QTR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS